Please assess the completion status of the following clinical trial:

Trial Title: Project 1: ACHIEVE- HTN

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* In order to be eligible to participate in this study, an individual must meet all of the following criteria:~  1. Self-identified Black/African Americans~ 2. Detroit-area residents (defined as those who attend attended a Detroit-area community event)~ 3. \> 18 years of age~ 4. Screening systolic BP 130-139 and diastolic BP \< 90 mm Hg~ 5. Not currently taking medications for HTN (Untreated)~ 6. 10-year cardiovascular risk \< 10% per ASCVD calculator (as such nearly all patients will be \<50-55 years of age)~ 7. Baseline home systolic BP 120-159 mm Hg and diastolic BP \< 100 mm Hg~Exclusion Criteria:~* An individual who meets any of the following criteria will be excluded from participation in this study:~  1. History of clinical cardiovascular disease (CVD)~ 2. History of kidney disease or eGFR \<60 mL/min from screening labs~ 3. Self-reported pregnancy (or planning to be pregnant in the next year)~ 4. History of diabetes or HbA1c \> 6.5% from SOC screening labs~ 5. Non-HDL-C \> 220 mg/dL from SOC labs (potential genetic hyperlipidemia)~ 6. Arm circumference \> 18'' (home BP arm cuff will be inaccurate)~ 7. Baseline home BP average \> 160mm Hg systolic and/or \>100 mm Hg diastolic

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: t

Study Arms:
- PAL2 Intervention (Type: EXPERIMENTAL): Overall study cohort will be enrolled into non-randomized active treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).